Effectiveness of omalizumab in patients with severe allergic asthma with and without chronic rhinosinusitis with nasal polyps: a PROXIMA study post hoc analysis

BACKGROUND: A significant proportion of patients with severe asthma may also suffer from nasal polyposis, which is commonly defined as chronic rhinosinusitis with nasal polyps (CRSwNP), the presence of which may adversely affect asthma treatment outcomes. The biologic agent omalizumab is effective a...

Descripción completa

Detalles Bibliográficos
Autores principales: Heffler, Enrico, Saccheri, Fabiana, Bartezaghi, Marta, Canonica, Giorgio Walter
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2020
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318524/
https://www.ncbi.nlm.nih.gov/pubmed/32607141
http://dx.doi.org/10.1186/s13601-020-00330-1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7318524/
https://www.ncbi.nlm.nih.gov/pubmed/32607141
http://dx.doi.org/10.1186/s13601-020-00330-1

Ejemplares similares